Results 131 to 140 of about 1,955 (223)

Effect of Burosumab on Muscle Function and Strength, and Rates of ATP Synthesis in Skeletal Muscle in Adults With XLH [PDF]

, 2023
Karl Insogna, Rebecca Sullivan, Stephen Parziale, Yanhong Deng, Diana Carrano, Christine Simpson, Sylvie Dufour, Thomas O. Carpenter, Kitt Falk Petersen   +8 more
openalex   +1 more source

A Randomized, Double-Blind, Placebo-Controlled, Phase 3 Trial Evaluating the Efficacy of Burosumab, an Anti-FGF23 Antibody, in Adults With X-Linked Hypophosphatemia: Week 24 Primary Analysis [PDF]

, 2018
Karl Insogna, Karine Briot, Erik A. Imel, Peter Kamenický, Mary D. Ruppe, Anthony A. Portale, Thomas J. Weber, Pisit Pitukcheewanont, Hae Il Cheong, Suzanne M. Jan de Beur, Yasuo Imanishi, Nobuaki Ito, Robin Lachmann, Hiroyuki Tanaka, Farzana Perwad, Lin Zhang, Chaoyin Chen, Christina Theodore‐Oklota, Matt Mealiffe, Javier San Martín, Thomas O. Carpenter, on behalf of the AXLES 1 Investigators   +21 more
openalex   +1 more source

Burosumab Improves Patient-Reported Outcomes in Adults With Tumor-Induced Osteomalacia: Mixed-Methods Analysis [PDF]

, 2023
Suzanne M. Jan de Beur, Tricia Cimms, Annabel Nixon, Christina Theodore‐Oklota, Diana Luca, Mary Scott Roberts, Shayna Egan, Christina Graham, Elizabeth Hribal, Christopher J. Evans, Sue Wood, Angela Williams   +11 more
openalex   +1 more source

POSC132 A Mapping Exercise and Temporal Extrapolation of the WOMAC Index for Adults with X-Linked Hypophosphataemia (XLH) Treated with Burosumab [PDF]

, 2022
Ron L. Evans, Angela Williams, Matt Nixon, Neil Hawkins   +3 more
openalex   +1 more source

Review for "Interim Analysis of a Phase 2 <scp>Open‐Label</scp> Trial Assessing Burosumab Efficacy and Safety in Patients With <scp>Tumor‐Induced</scp> Osteomalacia"

, 2020

openalex   +1 more source

Review for "Burosumab for the Treatment of Tumor-Induced Osteomalacia"

, 2020

openalex   +1 more source

Crystal structure of the Fab fragment of burosumab, the first-in-class anti-FGF23 medicine for treating X-linked hypophosphatemia and tumor-induced osteomalacia

, 2021
Ui Beom Park, Hyun Tae Lee, Yu-Jin Kim, Tae Jun Jeong, Nahyun Gu, Yong‐Seok Heo   +5 more
openalex   +2 more sources

Progression of phosphaturic mesenchymal tumor in the femoral bone during treatment with burosumab: A case report

, 2023
Koichi Okajima, Hiroshi Kobayashi, Hayata Suzuki, Liuzhe Zhang, Yuki Ishibashi, Yusuke Tsuda, Munetoshi Hinata, Yoichi Yasunaga, Tetsuo Ushiku, Yuji Nakamoto, Yasuhiro Takeuchi, Sakae Tanaka   +11 more
openalex   +1 more source

Preoperative Burosumab With Delayed FGF23 Recovery and High Postoperative Bone Turnover in Tumor-Induced Osteomalacia. [PDF]

JCEM Case Rep
Yeh H, Nge HM, Ghimire A, Gordner C.
europepmc   +1 more source

SUN-356 Burosumab Resulted in Greater Clinical Improvements Compared with Higher-dose Conventional Therapy in Children with X-linked Hypophosphatemia (XLH)

, 2020
Erik A. Imel, Angel Chen, Ting Chang, Mary Scott Roberts, Leanne M. Ward   +4 more
openalex   +1 more source